<DOC>
	<DOCNO>NCT01792362</DOCNO>
	<brief_summary>This study prospective &amp; clinical trial compare basal 3 month diet anti-mullerian hormone level responder non-responders weight loss diet obese infertile woman PCOS population</brief_summary>
	<brief_title>Evaluation Anti-mullerian Hormone ( AMH ) Levels Predictive Factor Response Weight Loss Treatment Obese Infertile Women With Poly Cystic Ovary ( PCOS )</brief_title>
	<detailed_description>The study population comprise obese infertile PCOS patient age 20-40 year underwent 3 month weight loss diet royan institute , Tehran Iran . The study conduct 12 wk energy restriction . All subject dietary protocol . At baseline , week 12 level AMH , Follicular Stimulating Hormone ( FSH ) , Lutienizing Hormone ( LH ) , Prolactin ( PRL ) , androgens , sex hormone-binding globulin ( SHBG ) , glucose , insulin measure Free Androgen Index ( FAI ) Insulin Resistance ( IR ) index calculate . The laboratory test determine radioimmunoassay Laboratory Endocrinology Royan institute . AMH measure duplicate use ultrasensitive ELISA kit ( AMH-ELIZA Kit ; Beckman Coulter , Marseilles , France ) accord manufacturer instruction . All measurement perform use single kit time Laboratory clinical Immunology Royan institute . Data collection perform use questionnaire fill per available record laboratory result . Data analysis do descriptive perceptive statistical method .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>1 diagnosis PCOS , accord Rotterdam Consensus Workshop Group , 2 follow 3 criterion : menstrual irregularity ( cycle length &lt; 26 &gt; 31 variation consecutive cycle &gt; 3 ) ; clinical ( hirsutism assess FerrimanGallwey score &gt; 8 ) biochemical [ free androgen index ( FAI ) &gt; 5.4 testosterone_1.4 nmol/L ] hyperandrogenism ; positive ultrasound presentation polycystic ovary transvaginal scan . 2 Age 18 40 1 . Body mass index ( BMI ; kg/m2 ) &lt; 30 , 2 . Type 2 diabetes mellitus related endocrinopathic disorder [ identify assessment thyroidstimulating hormone ( TSH ) , prolactin , 17_hydroxyprogesterone ] . 3 . Regular exercise activity study . 4 . Cases alcoholism smoke . 5 . The use endocrine hormonal treatment insulinsensitizing agent permit either phase study , use oral contraceptive permit study . Subjects required cease take oral contraceptive 4 wk hormonal treatment insulinsensitizing agent 2 wk commencement shortterm study phase .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Anti-mullerian hormone ( AMH ) level , poly cystic ovarian syndrome obese infertility weight loss diet</keyword>
</DOC>